Lv3
330 积分 2023-07-03 加入
A phase 2a trial of the IL-33 mAb tozorakimab in patients with COPD: FRONTIER-4
8天前
已关闭
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
28天前
已完结
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
1个月前
已完结
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
1个月前
已完结
Benralizumab efficacy and safety in severe asthma: A randomized trial in Asia
2个月前
已完结
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study
2个月前
已完结
Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study
3个月前
已完结
Efficacy and Safety of Tacrolimus versus Cyclosporine A for Idiopathic Membranous Nephropathy:A Network Meta-analysis
3个月前
已完结
Membranous nephropathy treatment standard
3个月前
已完结
Efficacy and safety of tacrolimus combined with corticosteroids in patients with idiopathic membranous nephropathy: a systematic review and meta-analysis of randomized controlled trials
3个月前
已完结
皖公网安备34019202002308
